Anethole Supplementation During Oocyte Maturation Improves In Vitro Production of Bovine Embryos

• Published in: Reproductive sciences (Thousand Oaks, Calif.) Vol. 27; no. 8; pp. 1602 - 1608
• Main Authors: Sá, Naiza A. R., Vieira, Luís A., Ferreira, Anna Clara A., Cadenas, Jesús, Bruno, Jamily B., Maside, Carolina, Sousa, Francisca G. C., Cibin, Francielli W. S., Alves, Benner G., Rodrigues, Ana Paula R., Leal-Cardoso, José H., Gastal, Eduardo L., Figueiredo, José R.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.08.2020
• Subjects: Animals; Anisoles - administration & dosage; Cattle; Dietary Supplements; Embryology; Embryonic Development - drug effects; Embryonic Development - physiology; Female; In Vitro Oocyte Maturation Techniques - methods; Male; Medicine; Medicine & Public Health; Obstetrics/Perinatology/Midwifery; Oocytes - drug effects; Oocytes - growth & development; Original Article; Reproductive Medicine; anethole; embryo; antioxidant; oocyte; mitochondria; ROS
• ISSN: 1933-7191; 1933-7205
• DOI: 10.1007/s43032-020-00190-x

Oxidative stress is one of the most detrimental factors that affect oocyte developmental competence and embryo development in vitro. The impact of anethole supplementation to in vitro maturation (IVM) media on oocyte maturation and further bovine in vitro embryo production was investigated. Oocytes of slaughterhouse-derived bovine ovaries were placed in IVM with anethole at different concentrations of 30 (AN30), 300 (AN300), and 2000 μg/mL (AN2000), or without (control treatment). The oocytes were assessed for maturation rates, and for reactive oxygen species (ROS) and ferric reducing antioxidant power (FRAP) levels, and mitochondrial membrane potential. Embryo development was assessed by cleavage and blastocyst rates, and embryo cell number. The percentage of metaphase II oocytes were similar among the treatments (range, 77%-96%). Anethole at 300 μg/mL was the only treatment that yielded higher cleavage and embryo development (morula and blastocyst) rates compared to the control treatment. The ROS production in the oocytes after maturation did not differ among treatments. However, oocytes treated with anethole at 300 μg/mL had higher ( P < .05) FRAP and mitochondrial membrane potential compared to the control treatment. Furthermore, AN300 treatment increased ( P < .05) the average number of total cells in blastocysts compared to the control and AN30 treatments. The use of anethole at 300 μg/mL during IVM is suggested to improve the quantity and quality of bovine embryos produced in vitro. The beneficial effects of anethole on embryonic developmental competence in vitro seems to be related to its capacity to regulate the redox balance and improve mitochondrial function in oocytes and embryos.